Abstract
BackgroundRecombinant human growth hormone treatment can optimize growth potential; however, optimal outcomes are not always achieved for several reasons, including poor adherence. The overall objective of this project was to design a patient support program to maximize the chances of treatment success for people being treated with somatropin injection. An approach known as the behavior change wheel was used to enhance the development of the patient support program. The behavior change wheel provided a comprehensive framework to support the design of interventions.ObjectiveThe aim of this paper was to describe how the steps of the behavior change wheel were applied to the development of a patient support program for individuals with growth hormone deficiency undergoing treatment with somatropin.MethodsWe followed a series of steps that align to tenets of the behavior change wheel, namely, a narrative literature review to identify which behaviors needed to change and the potential drivers of and barriers to the behaviors, the selection of an intervention strategy and discrete behavior change techniques, and, finally, intervention specification.ResultsA recent systematic review identified a range of potentially modifiable factors found to have an influence on patient adherence to growth hormone treatment. Insights from the systematic review were used to guide the development of a patient support program. The final design of the patient support program consisted of four elements: (1) a personalization questionnaire to tailor support for each individual, (2) tailored reminder and support SMS text messages, (3) nurse-led phone calls, and (4) Easypod connect, an automated electronic autoinjector drug-delivery device with a transmitter and connection platform for Saizen (somatropin) that allows automatic recording, storage, and transmission of drug-usage data, thus providing insight into suboptimal adherence.ConclusionsThe patient support program that was designed is currently being piloted with patients to assess engagement with the program and determine its impact on patient outcomes. Results from the pilot will be used to further refine the program to ensure it meets user needs.
Highlights
Recombinant human growth hormone (r-hGH; somatropin) treatment is well established for children and adolescents with growth hormone deficiency [1]
We describe how the steps of the behavior change wheel were applied to the development of a patient support program for individuals with growth hormone deficiency who were prescribed somatropin; the duration of individual treatments varies depending on age at time of diagnosis, and in order to reach full height potential, are continued up to the age when bone growth stops
A narrative review of the literature on growth hormone deficiency treatments found that despite the potential of r-hGH treatment to optimize growth potential, optimal outcomes were not always achieved; it was proposed that poor adherence was a key contributor to this [2,20,21]
Summary
Recombinant human growth hormone (r-hGH; somatropin) treatment is well established for children and adolescents with growth hormone deficiency [1]. Research has shown that children with growth hormone deficiency may experience a psychosocial burden as a result of being physically different from their peers [3,4] This burden can continue into adulthood, if short stature persists, limiting both personal and professional success [3] as well as potentially having an impact on long-term health, since, as adults, they may have an increased risk of cardiovascular diseases [5]. Objective: The aim of this paper was to describe how the steps of the behavior change wheel were applied to the development of a patient support program for individuals with growth hormone deficiency undergoing treatment with somatropin. Results from the pilot will be used to further refine the program to ensure it meets user needs
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.